Sun, Jul 13, 2014, 10:05 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • frenzychess frenzychess Sep 14, 2013 1:57 AM Flag


    I've said before that Vascepa was the only drug to reduce LDL-C and triglycerides, I was wrong. Fenofibrates are the bees knees. They reduce LDL-C and raise HDL-C while having their way with triglycerides. The science is perfect. Except for the failed trials and side effects, fibrates as a class are exceptional. They get the numbers! All Vascepa gets are healthier patients.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • frenzy...

      the LDL-C lowering was due to the statins that were included in the treatment...AMR101 was the first trig lowering agent that did not have an accompanying rise in LDL-C..

      ": ) JL

      Sentiment: Strong Buy

    • In ACCORD, no benefit was shown, but they think if you dig deep enough there is a sub-group maybe that benefited. Maybe several sub-groups. The trial isn't like MARINE or ANCHOR or even JELIS. The numbers in those trials are the end results and that's all. The results of those trials are so encouraging words don't do them justice.

      Sentiment: Strong Buy

1.59-0.02(-1.24%)Jul 11 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Potbelly Corporation
NasdaqGSFri, Jul 11, 2014 4:00 PM EDT
DHT Holdings, Inc.
NYSEFri, Jul 11, 2014 4:03 PM EDT